Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01288040 · ClinicalTrials.gov registry record · Phase 1

Locomotor Training for Neurological Disease

A Phase 1 study, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.

Completed
Registry status
Phase 1
Development phase
92
Enrollment target

NCT01288040: Completed Phase 1 study, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.

NCT01288040 is a Phase 1 study that has completed, run by Hugo W. Moser Research Institute at Kennedy Krieger. The registered enrollment target is 92 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (53% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01288040, a Phase 1 study, has completed, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.

COMPLETED
Registry status
Phase 1
Development phase
92 participants
Enrollment target

Study Summary

The purpose of this study is to determine whether split belt training can be used to treat walking pattern deficits from stroke and to determine whether different schedules and types of long term training on a custom split belt treadmill are likely to change/improve walking symmetry.

Primary Outcome

To determine which schedule is showing more improvement different walking parameters will be investigated such as change in step length. Subjects will have markers placed at different joints on their body to allow our cameras to watch how their walking pattern changes during the duration of the study, to see if any improvements develop.

Interventions

  • BEHAVIORAL Split Belt treadmill

Trial Details

FieldValue
Enrollment Target 92 participants
Start Date 2011-01
Est. Completion 2015-01
Phase Phase 1

What the finished NCT01288040 record still lists

NCT01288040 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 92 participants, a relatively small participant target, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (53% higher).

The record links to 0 conditions, and to 1 intervention - of which Split Belt treadmill is the first listed.

NCT01288040 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01288040 about?

NCT01288040 is a clinical study titled "Locomotor Training for Neurological Disease". The purpose of this study is to determine whether split belt training can be used to treat walking pattern deficits from stroke and to determine whether different schedules and types of long term training on a custom split belt treadmill are likely to change/improve walking symmetry.

What is the current status of trial NCT01288040?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 92 participants. The study started on 2011-01. Estimated completion is 2015-01.

What interventions are being tested in trial NCT01288040?

The interventions under investigation include: Split Belt treadmill (BEHAVIORAL).

Who is sponsoring clinical trial NCT01288040?

This trial is sponsored by Hugo W. Moser Research Institute at Kennedy Krieger, which has 73 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01288040's enrollment target sits among peer trials

92 625th of 2000 higher than 1,375 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03184545 · 92 participants · Phase 3

    Comparing the Outcome of Electrical Stimulation and Physical Therapy in Patellofemoral Pain Syndrome

  • NCT04172532 · 92 participants · Phase 1

    Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer

  • NCT04508088 · 92 participants

    Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease

  • NCT04840602 · 92 participants · Phase 2

    Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01288040, the US trial registry maintained by the National Library of Medicine. NCT01288040 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.